Yinkang-004

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameYinkang-004
Drug Alias Nameanti-VEGFR2 biosimilar program (Yinkang Biopharma)
ClassificationBiologics > Biosimilar
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factor receptor 2
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYinkang Biopharma Inc.
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYinkang Biopharma Inc.
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A